跳至主要内容
临床试验/CTRI/2024/04/065793
CTRI/2024/04/065793尚未招募2/3 期

A Single Arm clinical study to evaluate the efficacy of Darvyadi Kwath in Diabetic Polyneuropathy.

Dr Swapnil Balasaheb Kedar1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2024年5月25日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
efficacy of Darvyadi Kwath will be assessed over the 28 days by objective parameters.

研究概览

简要总结

TO STUDY EFFECT OF DARVYADI KWATH GIVEN  40 ML TWICE A DAY ORALLY ON 30 PATIENTS WHO HAVING SYMPTOMS OF DIABETIC  POLYNEUROPATHY I.E. TINGLING SENSATION,BURNING SENSATION,PAIN,NUMBNESS ETC WITHIN 28 DAYS WITH TWO FOLLOW UPSDUE TO CHRONIC ILLNESS OF DIABETES MELLITUS.FINAL CONCLUSION WILL BE DRAWN ON THE BASIS OF STATISTICAL METHODS.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
25.00 Year(s) 至 75.00 Year(s)(—)
性别
All

入选标准

  • A known Diabetic on treatment.
  • Patient who are not taking any medications for Diabetic Polyneuropathy And having symptoms of Diabetic Polyneuropathy.

排除标准

  • Pregnant lactating women.
  • Patients with pulmonary tuberculosis, cardiac complications, Renal complications, sciatica, cord compression, Immunocompromised patients, malignancies.
  • Vitamin B12 deficiency.

结局指标

主要结局

efficacy of Darvyadi Kwath will be assessed over the 28 days by objective parameters.

时间窗: 28 Days study. | Follow up on 14th and 28th days

次要结局

  • To study the Distal Symmetric Polyneuropathy in Diabetes under the subjective(measurement of Toronto Clinical scoring scale.)

研究者

发起方
Dr Swapnil Balasaheb Kedar
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr. Swapnil Balasaheb Kedar

Dr D Y Patil College Of Ayurved and Research Centre

研究点 (1)

Loading locations...

相似试验